• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主遗传因素 HLA 和 IL28B 作为聚乙二醇干扰素和利巴韦林治疗反应预测因子的重要性。

Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin.

机构信息

Unidad de Aparato Digestivo, Hospital Universitario San Cecilio, Granada, Spain.

出版信息

Am J Gastroenterol. 2011 Jul;106(7):1246-54. doi: 10.1038/ajg.2011.82. Epub 2011 Jun 14.

DOI:10.1038/ajg.2011.82
PMID:21670772
Abstract

OBJECTIVES

Viral factors are considered the best predictors of response to treatment for chronic hepatitis C (CHC), but genetic factors are known to have an important role in this respect. This paper investigates the relationships among the host genetic factors HLA and IL28B, viral factors, and the outcome of combination therapy.

METHODS

A multicenter retrospective cohort of 428 previously untreated CHC patients was treated with pegylated interferon/ribavirin (pegIFN/RBV) for 48 weeks. In all, 378 (88%) of these patients were genotype 1 or 4, and 50 (12%) were genotype 2 or 3.

RESULTS

Multivariate logistic regression showed the rs12979860 CC genotype (adjusted odds ratio (aOR)=4.3, 95% confidence interval (95% CI): 2.6-7), the HLA-DQB10301 allele (aOR=2.08, 95% CI: 1.2-3.5) and age, viral genotype, and viral load levels to be significantly associated with sustained virological response (SVR). When the variable rs12979860 was eliminated, the area under the receiver operating characteristic (ROC) curve (AUC) decreased significantly (0.76 vs. 0.69; P=0.03). AUC values derived from viral factors were lower than those corresponding to host genetic factors (0.67 vs. 0.72, respectively; P=0.04). The HLA-DQB10301 and A*0201 alleles were associated with rs12979860 CC genotype and SVR (P<0.0001).

CONCLUSIONS

The HLA-DQB10301 allele and IL28B genotype are factors that are associated independently with SVR. There is a synergism between the HLA-DQB10301 and HLA-A*0201 alleles with polymorphism rs12979860 CC, which increases the SVR rate. IL28B genotype is the best predictor of SVR.

摘要

目的

病毒因素被认为是慢性丙型肝炎(CHC)治疗反应的最佳预测因子,但遗传因素在这方面也起着重要作用。本文研究了宿主遗传因素 HLA 和 IL28B、病毒因素与联合治疗结局之间的关系。

方法

对 428 例未经治疗的 CHC 患者进行了多中心回顾性队列研究,这些患者接受聚乙二醇干扰素/利巴韦林(pegIFN/RBV)治疗 48 周。其中,378 例(88%)患者为基因型 1 或 4 型,50 例(12%)患者为基因型 2 或 3 型。

结果

多变量逻辑回归显示,rs12979860 CC 基因型(调整优势比(aOR)=4.3,95%置信区间(95%CI):2.6-7)、HLA-DQB10301 等位基因(aOR=2.08,95%CI:1.2-3.5)和年龄、病毒基因型和病毒载量水平与持续病毒学应答(SVR)显著相关。当排除变量 rs12979860 时,受试者工作特征(ROC)曲线下面积(AUC)显著降低(0.76 与 0.69;P=0.03)。来自病毒因素的 AUC 值低于对应宿主遗传因素的 AUC 值(分别为 0.67 与 0.72,P=0.04)。HLA-DQB10301 和 A*0201 等位基因与 rs12979860 CC 基因型和 SVR 相关(P<0.0001)。

结论

HLA-DQB10301 等位基因和 IL28B 基因型是与 SVR 独立相关的因素。HLA-DQB10301 等位基因与 HLA-A*0201 等位基因与 rs12979860 CC 多态性的协同作用增加了 SVR 率。IL28B 基因型是 SVR 的最佳预测因子。

相似文献

1
Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin.宿主遗传因素 HLA 和 IL28B 作为聚乙二醇干扰素和利巴韦林治疗反应预测因子的重要性。
Am J Gastroenterol. 2011 Jul;106(7):1246-54. doi: 10.1038/ajg.2011.82. Epub 2011 Jun 14.
2
High resolution melting curve assay for detecting rs12979860 IL28B polymorphisms involved in response of Iranian patients to chronic hepatitis C treatment.用于检测参与伊朗慢性丙型肝炎患者治疗反应的rs12979860 IL28B基因多态性的高分辨率熔解曲线分析
Asian Pac J Cancer Prev. 2015;16(5):1873-80. doi: 10.7314/apjcp.2015.16.5.1873.
3
Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.IL28B基因变异rs12979860和rs8099917对慢性丙型肝炎4型患者联合治疗病毒学应答的强大预测作用
Liver Int. 2014 Jul;34(6):890-5. doi: 10.1111/liv.12321. Epub 2013 Oct 14.
4
Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection.慢性丙型肝炎病毒感染的血液透析患者中低病毒载量的相关性。
World J Gastroenterol. 2015 May 14;21(18):5496-504. doi: 10.3748/wjg.v21.i18.5496.
5
Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1.胰岛素抵抗削弱了 IL28B 多态性在聚乙二醇干扰素 α-2b 和利巴韦林治疗基因 1 型慢性丙型肝炎患者中的优势。
J Hepatol. 2012 Sep;57(3):534-40. doi: 10.1016/j.jhep.2012.04.027. Epub 2012 May 18.
6
KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C.KIR3DL1-HLA-Bw4组合及IL28B基因多态性可预测慢性丙型肝炎患者接受聚乙二醇干扰素联合利巴韦林治疗(无论是否联用特拉匹韦)的疗效。
Hum Immunol. 2014 Aug;75(8):822-6. doi: 10.1016/j.humimm.2014.06.003. Epub 2014 Jun 11.
7
Prevalence of rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.rs4803217单核苷酸多态性的患病率与慢性丙型肝炎的临床病程
World J Gastroenterol. 2017 Jun 7;23(21):3815-3824. doi: 10.3748/wjg.v23.i21.3815.
8
Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data.预测慢性丙型肝炎治疗反应:一种结合白细胞介素-28B 基因多态性和临床数据的方法。
J Gastroenterol Hepatol. 2012 Feb;27(2):279-85. doi: 10.1111/j.1440-1746.2011.06834.x.
9
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4.白细胞介素 28B 多态性预测聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎基因型 4 的疗效。
Hepatology. 2012 Feb;55(2):336-42. doi: 10.1002/hep.24683. Epub 2012 Jan 3.
10
The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.IL28B、IFNL4和HLA基因的遗传变异对慢性丙型肝炎病毒感染治疗反应的影响。
Infect Genet Evol. 2017 Oct;54:330-337. doi: 10.1016/j.meegid.2017.07.023. Epub 2017 Jul 21.

引用本文的文献

1
The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune response.HCV 在病毒 HLA-Ag 结合中的抗原变异性与宿主免疫反应的激活有关。
Sci Rep. 2017 Nov 14;7(1):15513. doi: 10.1038/s41598-017-15605-0.
2
Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C.慢性丙型肝炎坏死性炎症活动的干扰素相关基因标志物。
PLoS One. 2017 Jul 12;12(7):e0180927. doi: 10.1371/journal.pone.0180927. eCollection 2017.
3
Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children.
HLA I类、HLA II类及杀伤细胞免疫球蛋白样受体对儿童丙型肝炎病毒垂直传播及慢性化的影响
PLoS One. 2017 Feb 22;12(2):e0172527. doi: 10.1371/journal.pone.0172527. eCollection 2017.
4
Genetic Variation in the IL-6 and HLA-DQB1 Genes Is Associated with Spontaneous Clearance of Hepatitis C Virus Infection.白细胞介素-6基因和人类白细胞抗原-DQB1基因的遗传变异与丙型肝炎病毒感染的自发清除有关。
J Immunol Res. 2016;2016:6530436. doi: 10.1155/2016/6530436. Epub 2016 Jun 2.
5
A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients.一个位于 HLA Ⅱ类区域附近的新的多态性与中国患者 HCV 的自发清除和对干扰素治疗的反应相关。
J Hum Genet. 2016 Apr;61(4):301-5. doi: 10.1038/jhg.2015.145. Epub 2015 Dec 3.
6
Hepatitis C virus (HCV) genotype 2a has a better virologic response to antiviral therapy than HCV genotype 1b.丙型肝炎病毒(HCV)2a基因型对抗病毒治疗的病毒学应答比HCV 1b基因型更好。
Int J Clin Exp Med. 2015 May 15;8(5):7446-56. eCollection 2015.
7
Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis.白细胞介素28B基因多态性作为慢性丙型肝炎持续病毒学应答的预测指标:系统评价与荟萃分析
Pharmacogenomics J. 2016 Feb;16(1):18-29. doi: 10.1038/tpj.2015.28. Epub 2015 Apr 28.
8
Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis.IL28B基因变异对丙型肝炎病毒诱导的肝纤维化、炎症和脂肪变性的影响:一项荟萃分析
PLoS One. 2014 Mar 17;9(3):e91822. doi: 10.1371/journal.pone.0091822. eCollection 2014.
9
Variation of transaminases, HCV-RNA levels and Th1/Th2 cytokine production during the post-partum period in pregnant women with chronic hepatitis C.慢性丙型肝炎孕妇产后期间转氨酶、HCV-RNA 水平和 Th1/Th2 细胞因子产生的变化。
PLoS One. 2013 Oct 10;8(10):e75613. doi: 10.1371/journal.pone.0075613. eCollection 2013.
10
Association between vitamin D and hepatitis C virus infection: a meta-analysis.维生素 D 与丙型肝炎病毒感染的关系:荟萃分析。
World J Gastroenterol. 2013 Sep 21;19(35):5917-24. doi: 10.3748/wjg.v19.i35.5917.